2-phenyl-benzimidazol and 2-phenyl-imidazo-4,5]-pyridine derivatives as checkpoint kinase CDS1 (CHK2) inhibitors for the treatment of cancer
Basic Information
ID: ALA3882722
Title: 2-phenyl-benzimidazol and 2-phenyl-imidazo-4,5]-pyridine derivatives as checkpoint kinase CDS1 (CHK2) inhibitors for the treatment of cancer
Patent ID: EP-1613313-B1
Associated Items: Associated Bioactivities Associated Assays Associated Compounds Associated Targets